Renaissance Capital logo

Micro-cap substance abuse program provider Catasys prices Nasdaq uplisting at $4.80

April 26, 2017
CATS

Catasys, which provides substance abuse, depression and anxiety outpatient programs, raised $15 million by offering 3.1 million shares at $4.80, below the OTC close of $10.00. Catasys plans to list on the Nasdaq under the symbol CATS. Joseph Gunnar & Co. acted as a lead manager on the deal.